Keyphrases
Cardiomyopathy
98%
Hypertrophic Cardiomyopathy
76%
Catecholaminergic Polymorphic Ventricular Tachycardia
65%
Arrhythmia
48%
Dilated Cardiomyopathy
43%
AMP-activated Protein Kinase
42%
Human Induced Pluripotent Stem Cell-derived Cardiomyocytes (hiPSC-CMs)
39%
Heart Transplantation
39%
Reperfusion
38%
Heart Failure
37%
Diabetic Cardiomyopathy
37%
Left Ventricular Ejection Fraction
35%
PRKAG2
35%
LAMP2
34%
Cardiomyocytes
33%
Induced Pluripotent Stem Cells (iPSCs)
33%
Heme oxygenase-1 (HO-1)
33%
CASQ2
30%
Danon Disease
30%
Ventricular Arrhythmia
30%
Ischemia
30%
Acute Decompensated Heart Failure
28%
PGC-1
28%
Duchenne muscular Dystrophy
26%
Glycogen Storage Disease
26%
Israel
26%
Heart Failure Patients
24%
Ca2+
24%
Left Ventricular Function
23%
Obesity
23%
Cardiac Hypertrophy
23%
Caloric Restriction
23%
Hypertrophic Obstructive Cardiomyopathy
21%
Calsequestrin
21%
Amyloidosis
21%
Mouse Model
20%
Glycogen
20%
Pericardial Disease
19%
Coactivator
19%
Gene mutation
19%
Clinical Outcomes
19%
Sirtuin 1 (SIRT1)
18%
Left Ventricular Hypertrophy
18%
Acute Heart Failure
18%
Ventricular Pre-excitation
18%
Oxidative Stress
18%
Electrophysiological Characteristics
18%
Isolated Rat Heart
18%
Mutant Mice
17%
Myocardial Injury
17%
Pharmacology, Toxicology and Pharmaceutical Science
Cardiomyopathy
100%
Heart Failure
86%
Heart Arrhythmia
62%
Disease
61%
Hypertrophic Cardiomyopathy
50%
Mouse
49%
Catecholaminergic Polymorphic Ventricular Tachycardia
45%
Hydroxymethylglutaryl Coenzyme A Reductase Kinase
38%
Diabetic Cardiomyopathy
37%
Ischemia
37%
Calcium Ion
33%
Congestive Cardiomyopathy
29%
Heart Ventricle Arrhythmia
29%
Calsequestrin
27%
Mouse Mutant
22%
Heme Oxygenase 1
21%
Symptom
19%
Heart Ventricle Hypertrophy
19%
Antiarrhythmic Agent
19%
Cardiovascular Disease
19%
Acute Heart Failure
17%
Angiotensin
17%
Mitral Valve Regurgitation
17%
Inflammation
16%
Prevalence
16%
Diabetes Mellitus
16%
Mouse Model
16%
Pericarditis
16%
Atrial Natriuretic Factor
16%
Hypertrophic Obstructive Cardiomyopathy
16%
Fibrosis
15%
Danon Disease
15%
Adenosine Phosphate
15%
Obstruction
15%
Angiotensin II
14%
Heart Left Ventricle Hypertrophy
13%
Antioxidant
13%
Wolff Parkinson White Syndrome
13%
Heart Muscle Injury
12%
Adverse Event
12%
Phosphotransferase
12%
Recurrent Disease
12%
Heart Ventricle Tachycardia
11%
Receptor
11%
Systolic Dysfunction
11%
Epileptic Absence
11%
Placebo
11%
Transgenic Mouse
10%
ATTR Amyloidosis
10%
Pyridostigmine
10%
Medicine and Dentistry
Cardiomyopathy
98%
Heart Failure
93%
Hypertrophic Cardiomyopathy
53%
Disease
49%
Heart Transplantation
38%
Heart Left Ventricle Ejection Fraction
31%
Dilated Cardiomyopathy
28%
Hydroxymethylglutaryl Coenzyme A Reductase Kinase
28%
Diabetes
25%
Exercise
25%
Danon Disease
25%
Prevalence
24%
Ventricular Hypertrophy
22%
Catecholaminergic Polymorphic Ventricular Tachycardia
21%
Pericarditis
21%
Ischemia
21%
Symptom
20%
Pericardial Disorder
19%
Diabetic Cardiomyopathy
19%
Diagnosis
18%
Adverse Event
18%
Cardiovascular System
18%
Cardiac Dysrhythmia
18%
Recurrent Disease
17%
Acute Decompensated Heart Failure
17%
Glycogen Storage Disease
17%
Caloric Restriction
17%
Cardiology
17%
Heart Left Ventricle Function
17%
Heart Amyloidosis
17%
Mitral Insufficiency
16%
Left Ventricular Hypertrophy
16%
Ejection Fraction
16%
Oxidative Stress
16%
Peripartum Cardiomyopathy
16%
Cardiomyopathy
16%
Hypertrophic Obstructive Cardiomyopathy
16%
Sarcomere
16%
Cardiac Muscle Cell
16%
Obstruction
15%
Amyloid
15%
Signal Transduction
14%
Diabetes Mellitus
14%
Transgenic Mouse
14%
Heart Ventricle Arrhythmia
14%
Amyloidosis
13%
Clinical Feature
13%
Renin Angiotensin Aldosterone System
13%
ATTR Amyloidosis
13%
Quality of Life
12%
